40 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2030. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Oct 2030

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030 2031 2032 2033 203420352036 2037 2038 2039 204020412042204320442045

notable patents all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

System for Extended Storage of Red Blood Cells and Methods of Use US 9,199,016

The most cited patent in this portfolio, cited by 81 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2032.

Ends Jun 2032 · Medium confidence Also notable

Anaerobic Blood Storage Containers US 9,801,784

Cited by 37 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2036.

Ends Apr 2036 · High confidence Also notable

Oxygen Reduction Disposable Kits, Devices and Methods of Use Thereof (ORDkit) US 11,350,626

Cited by 7 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.

Ends Mar 2036 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jun 1, 2027
The maintenance fee for System for Extended Storage of Red Blood Cells and Methods of Use (US 9,199,016) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
1 fee due Aug 27, 2027
The maintenance fee for Anaerobic Blood Storage and Pathogen Inactivation Method (US 11,911,471) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
2 fees due Sep 10 to 30, 2027 · next Sep 10

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 14 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Irradiation of Red Blood Cells and Anaerobic Storage	8 in force	to Aug 2033
Methods and Treatment of Trauma Adverse Events with Oxygen Reduced Blood	7 in force	to Sep 2038
Oxygen Reduction Disposable Kits, Devices and Methods of Use Thereof	5 in force	to Mar 2036
Anaerobic Blood Storage and Pathogen Inactivation Method	4 in force	to May 2037
Anaerobic Blood Storage Containers	3 in force	to May 2039

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 11,284,616	Irradiation of Red Blood Cells and Anaerobic Storage In force Term ends Oct 8, 2030 · Medium confidence	In force	Term ends Oct 8, 2030	Medium confidence
US 11,433,164	System for Extended Storage of Red Blood Cells and Methods of Use In force Term ends Oct 8, 2030 · Medium confidence	In force	Term ends Oct 8, 2030	Medium confidence
US 12,089,589	Irradiation of Red Blood Cells and Anaerobic Storage In force Term ends Oct 8, 2030 · Medium confidence	In force	Term ends Oct 8, 2030	Medium confidence
US 12,502,462	System for Extended Storage of Red Blood Cells and Methods of Use In force Term ends Oct 8, 2030 · Medium confidence	In force	Term ends Oct 8, 2030	Medium confidence
US 9,844,615	System for Extended Storage of Red Blood Cells and Methods of Use In force Term ends Nov 3, 2030 · Medium confidence	In force	Term ends Nov 3, 2030	Medium confidence
US 10,603,417	System for Extended Storage of Red Blood Cells and Methods of Use In force Term ends Apr 12, 2031 · Medium confidence	In force	Term ends Apr 12, 2031	Medium confidence
US 9,339,025	Method for Enhancing Red Blood Cell Quality and Survival During Storage In force Term ends Aug 25, 2031 · High confidence	In force	Term ends Aug 25, 2031	High confidence
US 9,199,016	System for Extended Storage of Red Blood Cells and Methods of Use In force Term ends Jun 24, 2032 · Medium confidence	In force	Term ends Jun 24, 2032	Medium confidence
US 10,251,387	Method for Enhancing Red Blood Cell Quality and Survival During Storage In force Ends no later than Dec 31, 2032 · Medium confidence	In force	Ends no later than Dec 31, 2032	Medium confidence
US 9,977,037	Capillary Network Devices and Methods of Use In force Term ends May 22, 2033 · High confidence	In force	Term ends May 22, 2033	High confidence

10 of 40 patents shown.

Pro members see all 40.

Pro members: see all 40 patents

Also on record, not counted in the 40: 1 patent ended · 21 applications pending · 7 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Hemanext Inc.